Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response.
Saved in:
| Title: | Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response. |
|---|---|
| Authors: | Dellon ES; Department of Medicine, Division of Gastroenterology and Hepatology, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Kosloski MP; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Shabbir A; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Glotfelty L; Sanofi, Bridgewater, New Jersey, USA ., Xu C; Sanofi, Bridgewater, New Jersey, USA ., Kamal MA; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA. |
| Source: | Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2025 Jan 01; Vol. 16 (1), pp. e00793. Date of Electronic Publication: 2025 Jan 01. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101532142 Publication Model: Electronic Cited Medium: Internet ISSN: 2155-384X (Electronic) Linking ISSN: 2155384X NLM ISO Abbreviation: Clin Transl Gastroenterol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2155-384X |
|---|---|
| DOI: | 10.14309/ctg.0000000000000793 |
